Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039480
Filing Date
2020-08-12
Accepted
2020-08-12 07:16:01
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrr-10q_20200630.htm   iXBRL 10-Q 2512557
2 EX-31.1 tcrr-ex311_6.htm EX-31.1 10673
3 EX-31.2 tcrr-ex312_7.htm EX-31.2 10628
4 EX-32.1 tcrr-ex321_8.htm EX-32.1 9540
5 GRAPHIC gmhii1t23gg1000001.jpg GRAPHIC 2978
  Complete submission text file 0001564590-20-039480.txt   7249215

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20200630.xsd EX-101.SCH 43073
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcrr-20200630_cal.xml EX-101.CAL 39865
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcrr-20200630_def.xml EX-101.DEF 127557
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20200630_lab.xml EX-101.LAB 377349
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20200630_pre.xml EX-101.PRE 271604
11 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-10q_20200630_htm.xml XML 1146809
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

EIN.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38811 | Film No.: 201094075
SIC: 2836 Biological Products, (No Diagnostic Substances)